Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 3
2005 1
2007 1
2009 1
2011 1
2012 1
2015 3
2016 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination.
Parés-Badell O, Zules-Oña R, Armadans L, Pinós L, Borrás-Bermejo B, Otero S, Rodrigo-Pendás JÁ, Vivet-Escalé M, Cossio-Gil Y, Agustí A, Aguilera C, Campins M, Martínez-Gómez X. Parés-Badell O, et al. Among authors: armadans l. Vaccines (Basel). 2022 Jul 29;10(8):1217. doi: 10.3390/vaccines10081217. Vaccines (Basel). 2022. PMID: 36016105 Free PMC article.
[Pneumococcal vaccination coverage in at-risk children in Catalonia].
González R, Armadans L, Martínez X, Moraga F, Campins M. González R, et al. Among authors: armadans l. Enferm Infecc Microbiol Clin. 2015 Nov;33(9):597-602. doi: 10.1016/j.eimc.2015.01.003. Epub 2015 Feb 19. Enferm Infecc Microbiol Clin. 2015. PMID: 25703208 Spanish.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013-2015 in Catalonia, Spain.
Godoy C, Peremiquel-Trillas P, Andrés C, Gimferrer L, Uriona SM, Codina MG, Armadans L, Martín Mdel C, Fuentes F, Esperalba J, Campins M, Pumarola T, Antón A. Godoy C, et al. Among authors: armadans l. Diagn Microbiol Infect Dis. 2016 Oct;86(2):153-9. doi: 10.1016/j.diagmicrobio.2016.07.023. Epub 2016 Jul 27. Diagn Microbiol Infect Dis. 2016. PMID: 27524509 Free PMC article.
17 results